Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator
Article in Frontiers in Pharmacology (February 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Estimating Time Window to Administer Anti-Cytokine Therapeutic Drugs to COVID-19 Patients
Article in IEEE Transactions on NanoBioscience (January 2024)
Impact of early tocilizumab administration on the progression of respiratory failure in COVID-19 patients
Article in PULMONOLOGIYA (April 2023)